South American Thoracic Stent-Graft Study

TriVascular, Inc.2 enrolled

Overview

A prospective, non-randomized multi-center clinical evaluation of the performance of the TriVascular Thoracic Stent Graft System when used in the treatment of subjects with thoracic aortic aneurysms (TAA).

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Thoracic Aortic Aneurysm

Interventions

Implant Thoracic Stent GraftDEVICE

Endovascular implant of Thoracic Aortic Aneurysm Stent Graft

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The TriVascular Thoracic Stent Graft System is indicated in subjects diagnosed with an aneurysm in the descending thoracic aorta having vascular morphology suitable for endovascular repair, including: * Adequate iliac/femoral access compatible with the required delivery systems, * Non-aneurysmal aortic segments proximal and distal to the aneurysm.

Locations (1)

Pontificia Universidad Caolica de Chile

Santiago, Chile

Outcomes

Primary Outcomes

Absence of device-related serious adverse events within 30-days of endovascular procedure

Time frame: 30-Days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.